Ekso Bionics Holdings Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Edison Investment Research
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Ekso Bionics Holdings Inc announces unregistered sales of equity securities - Form 8-K
Ekso Bionics Holdings Inc:Says on Jan. 29, the company completed a second closing of the private placement offering (the PPO).Says the company issued and sold 6,856,500 additional Units of securities, at a purchase price of $1.00 per Unit.Says each Unit consisting of one share of the company’s common stock, $0.001 par value per share and a warrant to purchase one share of Common Stock at an exercise price of $2.00 per share and with a term of five years.Says the aggregate additional gross proceeds from the second closing of the PPO were $6,856,500 (before deducting placement agent fees and expenses estimated at about $694,000).
Latest Developments for Ekso Bionics Holdings Inc
Latest Key Developments in Medical
- IDEXX Laboratories Inc lowers FY 2014 revenue guidance; raises FY 2014 EPS guidance; gives FY 2015 guidance above analysts' estimates
- Japan Lifeline Co Ltd revises consolidated mid-year outlook for FY 2015
- Japan Lifeline Co Ltd raises consolidated full-year outlook for FY 2015
- Vigmed Holding publ AB announces right issue
- Share this
- Digg this